SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-016705
Filing Date
2021-12-13
Accepted
2021-12-13 08:05:36
Documents
13
Period of Report
2021-12-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aytu-20211213x8k.htm   iXBRL 8-K 35499
2 EX-99.1 aytu-20211213xex99d1.htm EX-99.1 15610
  Complete submission text file 0001558370-21-016705.txt   176964

Data Files

Seq Description Document Type Size
3 EX-101.SCH aytu-20211213.xsd EX-101.SCH 3035
4 EX-101.LAB aytu-20211213_lab.xml EX-101.LAB 16081
5 EX-101.PRE aytu-20211213_pre.xml EX-101.PRE 10212
6 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20211213x8k_htm.xml XML 4920
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 211487004
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences